The tourists from India, who were vaccinated by the AstraZeneca/CoviShield, cannot enter the EU with their vaccination certificates because the EMA has not licensed for the EU the “Indian variant” of AstraZeneca as Reuters reported.
Thus, CEO of Serum Institute of India Adar Poonawalla stated on Monday that he tries to solve the issues with the travels to the EU faced by the Indians.
“I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla stated on Twitter.
I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the E.U., I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries.— Adar Poonawalla (@adarpoonawalla) June 28, 2021
The Foreign Ministry of India raised the issue of the non-recognition of CoviShield by the EMA.
CoviShield does not have permission for sale in the EU; however, it can be the production line similar to Vaxzevria.
“Should we receive a marketing authorisation application for CoviShield or should any change to the approved manufacturing sites for Vaxzevria be approved, we would communicate about it," the EMA said.
The EMA states that the vaccines that received permission for sale in the EU should also be admitted for the certificate; while the state members can also admit the vaccines approved by the WHO.
According to the new rules, the tourists can freely travel in the EU from July 1, if they have the vaccination certificate with one out of four vaccines certified by the EMA. The list includes AstraZeneca (Vaxzervia), Moderna, Pfizer/BioNTech, and Johnson & Johnson.
In Ukraine, the CoviShield and South Korean variant of AstraZeneca are used.